4/A: Neurogene Director Keith Woods Files Amended Form 4
Form 4/A Amendment
Director Keith Woods refiled a Form 4 to correct a CIK number error regarding a previously reported stock option grant.
Summary
- Director Keith Woods received a grant of 7,700 stock options on June 14, 2024.
- The options have an exercise price of $42.59 and are fully vested.
- This filing is an amendment to a June 17, 2024, filing to correct an incorrect CIK number for the reporting person.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative update with no impact on the company's fundamental outlook.
Positives
- The director maintains an equity-based incentive alignment with the company through the option grant.
Negatives
- Administrative error in the original filing necessitated this amendment.
Risks
- None identified in this administrative filing.
Future Outlook
No forward-looking guidance provided in this administrative filing.
Industry Context
StockSavvy.ai notes that this is a routine administrative correction for a biotechnology company, reflecting standard corporate governance and regulatory compliance procedures.
Comparison to Industry Standards
- The grant of fully vested options to directors is a common practice in the biotechnology sector to align interests with shareholders.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Administrative Correction | Correction of CIK number in SEC filing. | 06/14/2024 | None; purely clerical. |
Stakeholder Impact
- No material impact on shareholders or other stakeholders.
Next Steps
- No further actions required.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of the stock option grant transaction. |
| 06/17/2024 | Date of the original filing that contained the CIK error. |
| 06/16/2026 | Date listed on the signature line of the amended filing. |
Keywords
Neurogene, NGNE, Form 4, Insider Trading, Director Compensation, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.